top of page

Publicações de 2014

de Souza RD, Batista MT, Luiz WB, Cavalcante RC, Amorim JH, Bizerra RS, Martins EG, Ferreira LC. Bacillus subtilis spores as vaccine adjuvants: further insights into the mechanisms of action. PLoS One. 2014 Jan 27;9(1):e87454.

 

Acesse Aqui:

 

 

 

Amorim, Jaime Henrique ; ALVES, RÚBENS PRINCE DOS SANTOS ; BOSCARDIN, SILVIA BEATRIZ ; FERREIRA, LUÍS CARLOS DE SOUZA . The dengue virus non-structural 1 protein: Risks and benefits. Virus Research (Print), v. 181, p. 53-60, 2014.

 

Acesse Aqui:

 

 

 

Braga CJ, Rodrigues JF, Medina-Armenteros Y, Farinha-Arcieri LE, Ventura AM, Boscardin SB, Sbrogio-Almeida ME, Ferreira LC. Parenteral Adjuvant Effects of an Enterotoxigenic Escherichia coli Natural Heat-Labile Toxin Variant. Frontiers in immunology. 2014 Jan 7; 4:487.

 

Acesse Aqui:

 

 

 

Tavares Batista M, Souza RD, Paccez JD, Luiz WB, Ferreira EL, Cavalcante RC, Ferreira RC, Ferreira LC. Gut Adhesive Bacillus subtilis Spores as a Platform for Mucosal Delivery of Antigens. Infection and immunity. 2014 Apr;82(4):1414-23.  Jan 13, 2014.

 

Acesse Aqui:

 

 

 

Alves RPS, Yang MJ, Batista MT and Ferreira LCS. Alzheimer's disease: is a vaccine possible?. Brazilian Journal of Medical and Biological Research. (2014) 47(6): 438-444

 

Acesse Aqui:

 

 

 

 

 de Melo F. M.;  Braga, C. J.; Pereira, F. V.; Maricato, J. T,; Origassa, C. S.;, Souza M. F.; Melo, A. C.; Silva, P; Tomaz, S. L.; Gimenes, K. P.; Scutti, J. A.; Juliano, M. A.; Zamboni, D. S, Câmara, N. O, Travassos, L. R; Ferreira, L. C.; Rodrigues, E. G. Anti-metastatic immunotherapy based on mucosal administration of flagellin and immunomodulatory P10. Immunology and cell biology. v.93(1):86-98. 2015.

 

Acesse Aqui:

 

 

 

Batista, M. T.; Souza, R. D.; Ferreira, E. L.; Robinette, R.; Crowley, P. J.; Rodrigues, J. F.; Brady, L. J.; Ferreira, L. C.; Ferreira, R. C.  Immunogenicity and in vitro and in vivo protective effects of antibodies targeting a recombinant form of theStreptococcus mutans P1 surface protein. Infection and immunity82(12):4978-88. 2014.

 

Acesse Aqui:

 

 

 

NIZARD, M.; DINIZ, M. O.; ROUSSEL, H.; TRAN, T.; FERREIRA, L. C. S.; BADOUAL, C.; TARTOUR, E. Mucosal vaccines. Human Vaccines & Immunotherapeutics, v. 10, p. 2175-2187, 2014.

 

Acesse Aqui:

 

 

 

Amorim, J. H.; Jesus, M. R.; Luiz, W. B.; Porchia, B. F.; Ferreira, R. C.; Servat, E. G.; Ghiringhelli, P. D.; Ferreira, L. C.; Bentancor,  L. V. Role of bacteriophages in STEC infections: new implications for the design of prophylactic and treatment approaches. F1000 Research.  v. 18;3:74. 2014.

 

Acesse Aqui:

 

 

Borin, T. F.; Zuccari, D. A.; Jardim-Perassi, B. V.; Ferreira, L.C.; Iskander, A.S.; Varma, N. R.; Shankar, A.; Guo, A. M.; Scicli, G. Arbab, A. S. HET0016, a Selective Inhibitor of 20-HETE Synthesis, Decreases Pro-Angiogenic Factors and Inhibits Growth of Triple Negative Breast Cancer in Mice. PloS one. v. 30;9(12):e116247. 2014.

 

Acesse Aqui:

 

 

 

Hu, J. C.; Mathias-Santos, C.; Greene, C. J.; King-Lyons, N. D.; Rodrigues, J.F.; Hajishengallis, G.; Ferreira, L. C.; Connell, T. D. Intradermal Administration of the Type II Heat-Labile Enterotoxins LT-IIb and LT-IIc of Enterotoxigenic Escherichia coli Enhances Humoral and CD8+ T Cell Immunity to a Co-Administered Antigen. PLoS One. v. 23;9(12):e113978. 2014.

 

Acesse Aqui:

bottom of page